Thirty-Day Mortality Following Systemic Anticancer Therapy: Evaluating Risk Factors Without Selection Bias in a Real-World, Population-Based Cohort From 2009 to 2019

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalClinical Oncology
Volume34
Issue number8
Pages (from-to)487-496
Number of pages10
ISSN0936-6555
DOIs
Publication statusPublished - Aug 2022

Bibliographical note

Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Keywords

  • Antineoplastic drugs
  • monitoring tool
  • mortality risk factors
  • short-term mortality
  • Time Factors
  • Humans
  • Lung Neoplasms/drug therapy
  • Risk Factors
  • Selection Bias
  • Male
  • Cohort Studies

Fingerprint

Dive into the research topics of 'Thirty-Day Mortality Following Systemic Anticancer Therapy: Evaluating Risk Factors Without Selection Bias in a Real-World, Population-Based Cohort From 2009 to 2019'. Together they form a unique fingerprint.

Cite this